termsTerm
340B Drug Pricing Program
A US law that lets certain hospitals buy outpatient drugs, including cancer drugs, at deep discounts. Controversial because hospitals may bill insurers full price.
Enacted 1992; covered entities (disproportionate-share hospitals, federally qualified health centres) receive manufacturer discounts of 25-50%. It shapes where oncology infusions happen (hospital outpatient vs community practice), fuels hospital acquisition of oncology practices, and is under litigation and legislative pressure over contract pharmacies and rebate models.
Clinical: what this kind of term is about · animated schematic, not to scale
Category
Clinical